RB1 and retinoblastoma: Fewer than 2% of retinoblastomas lack aberrations in RB1 but display high-level amplification of MYCN. To date, only patients with intraocular disease MYCN amplified and RB1 wild-type patients (MYCNamplRB1+/+) have been reported [6].